TY - JOUR
T1 - Radiation Recall Pneumonitis
T2 - Imaging Appearance and Differential Considerations
AU - Jo, Nahyun Celina
AU - Shroff, Girish S.
AU - Ahuja, Jitesh
AU - Agrawal, Rishi
AU - Price, Melissa C.
AU - Wu, Carol C.
N1 - Publisher Copyright:
© 2024 The Korean Society of Radiology
PY - 2024/9
Y1 - 2024/9
N2 - Radiation recall pneumonitis is an inflammatory reaction of previously radiated lung parenchyma triggered by systemic pharmacological agents (such as chemotherapy and immunotherapy) or vaccination. Patients present with non-specific symptoms such as cough, shortness of breath, or hypoxia soon after the initiation of medication or vaccination. Careful assessment of the patient’s history, including the thoracic radiation treatment plan and timing of the initiation of the triggering agent, in conjunction with CT findings, contribute to the diagnosis. Once a diagnosis is established, treatment includes cessation of the causative medication and/or initiation of steroid therapy. Differentiating this relatively rare entity from other common posttherapeutic complications in oncology patients, such as recurrent malignancy, infection, or medication-induced pneumonitis, is essential for guiding downstream clinical management.
AB - Radiation recall pneumonitis is an inflammatory reaction of previously radiated lung parenchyma triggered by systemic pharmacological agents (such as chemotherapy and immunotherapy) or vaccination. Patients present with non-specific symptoms such as cough, shortness of breath, or hypoxia soon after the initiation of medication or vaccination. Careful assessment of the patient’s history, including the thoracic radiation treatment plan and timing of the initiation of the triggering agent, in conjunction with CT findings, contribute to the diagnosis. Once a diagnosis is established, treatment includes cessation of the causative medication and/or initiation of steroid therapy. Differentiating this relatively rare entity from other common posttherapeutic complications in oncology patients, such as recurrent malignancy, infection, or medication-induced pneumonitis, is essential for guiding downstream clinical management.
KW - Chemotherapy complication
KW - COVID-19-related complications
KW - Immunotherapy
KW - Radiation therapy
KW - Radiation-induced pneumonitis
UR - http://www.scopus.com/inward/record.url?scp=85202908717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85202908717&partnerID=8YFLogxK
U2 - 10.3348/kjr.2024.0334
DO - 10.3348/kjr.2024.0334
M3 - Article
C2 - 39197829
AN - SCOPUS:85202908717
SN - 1229-6929
VL - 25
SP - 843
EP - 850
JO - Korean Journal of Radiology
JF - Korean Journal of Radiology
IS - 9
ER -